The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients - PubMed (original) (raw)
Comparative Study
The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients
L M Austin et al. J Invest Dermatol. 1999 Nov.
Free article
Abstract
Psoriasis vulgaris is a skin disease potentially mediated by pro-inflammatory cytokines produced by type 1 lesional T cells. The capability of individual T cells to produce these cytokines in lesional skin is not known. In this study we measured the ability of lesional and peripheral blood T cells to produce intracellular interferon-gamma, tumor necrosis factor-alpha, interleukin-2, interleukin-4, and interleukin-10 proteins as detected by flow cytometric analysis. Cytokine synthesis was induced by activation with ionomycin/phorbol myristate acetate (in the presence of Brefeldin A, which inhibits the exocytosis of these cytokines). After stimulation, we found relatively high percentages of epidermal CD8 and CD4 T cells capable of producing interferon-gamma, tumor necrosis factor-alpha, and interleukin-2, whereas few T cells, < 11%, expressed interleukin-4 or interleukin-10. Hence both CD8+ and CD4+ T cells are capable of type 1 effector functions (TC1 and TH1, respectively). This activation scheme was repeated on peripheral blood T cells from psoriatic patients versus healthy controls, where we also found a type 1 bias. In order to evaluate quantitatively the type 1 cytokine bias, we compared the frequency of type 2 interleukin-4 producing versus type 1 interferon-gamma producing T cells in our assay and found a shift towards type 1 producing cells. This shift reveals a type 1 differentiation bias in both lesional areas and in the peripheral blood, which may indicate an imbalance within the T cell population, which is contributing to the chronic or sustained immunologic activation of T cells found in this disease.
Similar articles
- Restoration of Th1 cytokine synthesis by T cells of patients with chronic myelogenous leukemia in cytogenetic and hematologic remission with interferon-alpha.
Reuben JM, Lee BN, Johnson H, Fritsche H, Kantarjian HM, Talpaz M. Reuben JM, et al. Clin Cancer Res. 2000 May;6(5):1671-7. Clin Cancer Res. 2000. PMID: 10815885 - Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
Laranjeira P, Pedrosa M, Pedreiro S, Gomes J, Martinho A, Antunes B, Ribeiro T, Santos F, Trindade H, Paiva A. Laranjeira P, et al. Stem Cell Res Ther. 2015 Jan 5;6(1):3. doi: 10.1186/scrt537. Stem Cell Res Ther. 2015. PMID: 25559824 Free PMC article. - Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets.
Szabo SK, Hammerberg C, Yoshida Y, Bata-Csorgo Z, Cooper KD. Szabo SK, et al. J Invest Dermatol. 1998 Dec;111(6):1072-8. doi: 10.1046/j.1523-1747.1998.00419.x. J Invest Dermatol. 1998. PMID: 9856819 - Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.
Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Bata-Csorgo Z, et al. J Invest Dermatol. 1995 Jul;105(1 Suppl):89S-94S. doi: 10.1111/1523-1747.ep12316121. J Invest Dermatol. 1995. PMID: 7616005 Review. - The Role of CD8+ T-Cells and their Cytokines in the Pathogenesis of Psoriasis.
Volarić I, Vičić M, Prpić-Massari L. Volarić I, et al. Acta Dermatovenerol Croat. 2019 Sep;27(3):159-162. Acta Dermatovenerol Croat. 2019. PMID: 31542059 Review.
Cited by
- The Immunology of Psoriasis-Current Concepts in Pathogenesis.
Sieminska I, Pieniawska M, Grzywa TM. Sieminska I, et al. Clin Rev Allergy Immunol. 2024 Apr;66(2):164-191. doi: 10.1007/s12016-024-08991-7. Epub 2024 Apr 20. Clin Rev Allergy Immunol. 2024. PMID: 38642273 Free PMC article. Review. - Damage-Associated Molecular Patterns, a Class of Potential Psoriasis Drug Targets.
Gao Y, Gong B, Chen Z, Song J, Xu N, Weng Z. Gao Y, et al. Int J Mol Sci. 2024 Jan 7;25(2):771. doi: 10.3390/ijms25020771. Int J Mol Sci. 2024. PMID: 38255845 Free PMC article. Review. - Cellular Mechanisms of Psoriasis Pathogenesis: A Systemic Review.
Wu M, Dai C, Zeng F. Wu M, et al. Clin Cosmet Investig Dermatol. 2023 Sep 14;16:2503-2515. doi: 10.2147/CCID.S420850. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37727872 Free PMC article. Review. - Inflammatory Cues Direct Skin-Resident Type 1 Innate Lymphoid Cells to Adopt a Psoriasis-Promoting Identity.
Evers BDG, Hils M, Heuser C, Hölge IM, Argiriu D, Skabytska Y, Kaesler S, Posch C, Knolle PA, Biedermann T. Evers BDG, et al. JID Innov. 2023 Apr 25;3(4):100204. doi: 10.1016/j.xjidi.2023.100204. eCollection 2023 Jul. JID Innov. 2023. PMID: 37533580 Free PMC article. - Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology.
Mortlock RD, Ma EC, Cohen JM, Damsky W. Mortlock RD, et al. J Invest Dermatol. 2023 Aug;143(8):1412-1422. doi: 10.1016/j.jid.2023.04.005. Epub 2023 Jun 20. J Invest Dermatol. 2023. PMID: 37341663 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials